Final programme - eshre 2013

More documents

Recommendations

Info

Tuesday 9 July <strong>2013</strong>Selected oral communication session10.00 - 11.30 Capital Suite ASession 29: Ovarian stimulationChairman: E. Kolibianakis (Greece)Chairman: TBA10.00 o-105 Cumulative live birth rates following minimal ovarian stimulation/natural cycle IVF and singleembryo transfer in unselected infertile patients: a 3-year, single-centre, Japanese cohort studyD. Bodri, S. Kawachiya, M. Kondo, R. Kato, T. Matsumoto (Japan)10.15 O-106 The effect of the type of ovarian stimulation protocol on PGD results: a prospective randomised trialW. Verpoest, V. Vloeberghs, C. Staessen, A. Devos, M. De Rycke, M. Bonduelle, H. Tournaye,C. Blockeel (Belgium)10.30 o-107 kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatmentA. Abbara, C.N. Jayasena, G.M. Nijher, A.N. Comninos, G. Christopoulos, D. Ashby, M.A. Ghatei,S.R. Bloom, A. Carby, G. Trew, W.S. Dhillo (United Kingdom)10.45 o-108 a phase III assessor-blinded randomised multi-centre study to compare efficacy and safety oftwo r-hfsH formulations (afoLIA [Bemfola ® ] vs Gonal-f ® ) in women for assisted reproductivetreatmentB. Imthurn, M. Rettenbacher, E. Bemfola Study Group (Switzerland)11.00 o-109 Continued treatment with clomiphene citrate in subfertile women with World Health Organizationtype II anovulation who are not pregnant after six ovulatory cyclesN.S. Weiss, S. Braam, T.E. König, M.L. Hendriks, C.J. Hamilton, C. Koks, E.M. Kaaijk, M. van Wely,P.G.A. Hompes, C.B. Lambalk, B.W. Mol (The Netherlands)11.15 o-110 increased breast cancer risk after multiple implantation in IVF: a cohort studyE. Groeneveld, I.M. Krul, M. Spaan, A.W. van den Belt-Dusebout, T.M. Mooij, M.J. Lambers,J.W.R. Twisk, M. Hauptmann, P.G.A. Hompes, F.E. van Leeuwen, C.B. Lambalk, on behalf of theOMEGA-project group (The Netherlands)86
Tuesday 9 July <strong>2013</strong>Selected oral communication session10.00 - 11.30 Capital Hall BSession 30: Fertility preservation for medical and non-medical indicationsChairman: J.E.J. Smitz (Belgium)Chairman: H.M. Picton (United Kingdom)10.00 o-111 Cyclophosphamide triggers follicle activation causing ovarian reserve 'burn out'; AS101 preventsfollicle loss and preserves fertilityH. Roness, L. Kalich-Philosoph, A. Carmely, M. Fishel-Bartal, H. Ligumsky, S. Paglin,I. Wolf, H. Kanety, B. Sredni, D. Meirow (Israel)10.15 o-112 oocyte banking for anticipated gamete exhaustion (age): a follow-up studyD. Stoop, E. Maes, N.P. Polyzos, G. Verheyen, H. Tournaye, J. Nekkebroeck (Belgium)10.30 o-113 rapid warming increases survival rate of slow frozen (SF) oocytes; randomised controlled studyon sibling human oocytesL. Parmegiani, G.E. Cognigni, S. Bernardi, E. Troilo, A. Arnone, A.M. Maccarini, S. Lanzilotti,A. Rastellini, M. Filicori, G. Di Emidio, M. Vitti, C. Tatone (Italy)10.45 o-114 Bioengineered/biosynthetic supporting matrices for culturing human primordial follicles withphosphatidylinositol-trisphosphate (pip3)elevating substancesR. Abir, G. Lerer-Serfaty, N. Samara, A. Ben-Haroush, M. Shachar, O. Kossover, B. Fisch (Israel)11.00 o-115 dynamic perifusion culture initiates in vivo-like early follicular growth in prepubertal murineovarian tissueK. Winkler, V. Nederegger, S. Ayuandari, M. Salama, D. Rosenfellner, K.F. Murach,I. Zervomanolakis, S. Hofer, L. Wildt, S.C. Ziehr (Austria)11.15 o-116 a novel method for cryopreservation of very low count human spermatozoaA. Stein, S. Hadar, E. Kaisler, B. Fisch, H. Pinkas (Israel)TUESDAYProgramme book87
Page 1:
London - United Kingdom 7 to 10 Jul
Page 9 and 10:
Contents007 Welcome009 Committees01
Page 11:
Session 48:Session 49:Session 50:Se
Page 18 and 19:
Committee of National Representativ
Page 23 and 24:
GENERAL INFORMATION−−Political
Page 25 and 26:
Greater London is served by 12 Tube
Page 27:
GENERAL INFORMATIONProgramme book17
Page 32 and 33:
Monday 8 July 201308.00 - 17.30 IFF
Page 35 and 36:
Agenda of the 2013 Annual GeneralAs
Page 37:
AGENDAProgramme book25
Page 41:
SOCIAL PROGRAMMEOpening Ceremony an
Page 44 and 45:
COURSE 1Sunday, 7 July−−Room Ca
Page 46 and 47:
Chairman: Willem Ombelet (Belgium)1
Page 48 and 49:
New thoughtsChairman: Mariette Godd
Page 50 and 51: COURSE 5Sunday, 7 July−−Room Ca
Page 52 and 53: COURSE 7Sunday, 7 July−−−−
Page 58 and 59: COURSE 11Sunday, 7 July−−Room C
Page 60 and 61: course 12Sunday, 7 July−−Room C
Page 62 and 63: Course 13Sunday, 7 July−−Room C
Page 64 and 65: course 15Sunday, 7 JulyRoom Capital
Page 66 and 67: Overview MONDAY, 8 July 201308.00 -
Page 68 and 69: Monday 8 July 2013Invited session08
Page 70 and 71: Monday 8 July 2013Selected oral com
Page 80 and 81: Monday 8 July 2013Company symposium
Page 92 and 93: Overview TUESDAY, 9 July 201308.30
Page 94 and 95: Tuesday 9 July 2013Invited session0
Page 98 and 99: Tuesday 9 July 2013Selected oral co
Page 104 and 105: Tuesday 9 July 2013Company symposiu
Page 108 and 109: Tuesday 9 July 2013Company symposiu
Page 126 and 127: Overview Wednesday, 10 July 201308.
Page 128 and 129: Wednesday 10 July 2013Invited sessi
Page 134 and 135: Wednesday 10 July 2013Selected oral
Page 150 and 151:
136
Page 152 and 153:
Tuesday, 10 July13.00 P-050 Health
Page 154 and 155:
POSTERSAndrologyP-001 Magnetic Acti
Page 156 and 157:
P-028 Female age and number of retr
Page 158 and 159:
P-054 Genomic rearrangements and CN
Page 160 and 161:
P-079 A modified cryotop vitrificat
Page 162 and 163:
P-109 Effect of early blastomere mu
Page 164 and 165:
P-138 Cyclin E1 as a new ICM marker
Page 166 and 167:
P-167 Single medium culture in a ti
Page 168 and 169:
P-196 Early cleaving mouse embryos
Page 170 and 171:
P-225 Luteal phase support has a be
Page 172 and 173:
P-252 Correlation of histomorpholgy
Page 174 and 175:
P-283 Homologous intrauterine insem
Page 176 and 177:
P-310 Uterine contraction after emb
Page 178 and 179:
Paramedical - laboratoryP-335 To en
Page 180 and 181:
P-363 Effects of pharmacologically
Page 182 and 183:
P-393 "It is not his child, it is o
Page 184 and 185:
P-420 Differences in somatic cell g
Page 186 and 187:
P-446 Comparison between fresh or v
Page 188 and 189:
P-475 Use of ovarian reserve parame
Page 190 and 191:
P-503 Low follicular fluid tyrosine
Page 192 and 193:
P-531 Addition of luteal estradiol
Page 194 and 195:
P-557 Altered sensitivity rather th
Page 196 and 197:
P-585 A late presentation of obstru
Page 198 and 199:
184
Page 200 and 201:
Anastácio A. 60Andersen A.N. 80And
Page 202 and 203:
Bowman N. 55, 153Boyer P. 147Bozdag
Page 204 and 205:
Critchley H.O.D. 167Crivello A.M. 1
Page 206 and 207:
Farrag A. 143Farreras A. 149, 150Fa
Page 208 and 209:
Guarneri C. 143Gudi A. 57Guérif F.
Page 210 and 211:
Izzi-Engbeaya C. 177Izzo C.R. 148JJ
Page 212 and 213:
Kuchenbecker W.K.H. 182Kuchiki M. 1
Page 214 and 215:
Makedos A. 179Makyan Z. 134Malcov M
Page 216 and 217:
Nascimento A.M. 58, 73, 143,160, 17
Page 218 and 219:
Piccinini C.A. 166Piccolomini M. 17
Page 220 and 221:
Sanad A. 182Sanchez A.M. 158Sánche
Page 222 and 223:
Surlan L. 152, 164Sutcliffe A.G. 10
Page 224 and 225:
Velthut-Meikas A. 170Veltman D.J. 5
Page 226 and 227:
Zervomanolakis I. 87Zeyneloglu H.B.
Page 228:
Achevé d’imprimer par :
show all

Final programme - eshre 2013

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?